San Diego, CA -- (SBWIRE) -- 04/03/2017 -- The takeover of Exar Corporation is under investigation over potential wrongdoing. The investigation was announced on behalf of investors in NYSE:EXAR shares concerning whether the takeover of Exar Corporation by MaxLinear, Inc is unfair to NYSE:EXAR stockholders.

Investors who purchased shares of Exar Corporation (NYSE:EXAR) and currently hold any of those NYSE:EXAR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain directors of Exar Corporation breached their fiduciary duties owed to NYSE:EXAR investors in connection with the proposed acquisition.

On March 29, 2017, MaxLinear, Inc. (NYSE: MXL) and Exar Corporation (NYSE: EXAR) announced that they have entered into an agreement under which MaxLinear has agreed to acquire Exar for $13.00 per share in cash.

However, given that at least one analyst has set the high target price for NYSE:EXAR shares at $14.00 per share, the investigation concerns whether the offer is unfair to NYSE:EXAR stockholders. More specifically, the investigation concerns whether the Exar Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

On March 31, 2017, NYSE:EXAR shares closed at $13.01 per share.

Those who are current investors in Exar Corporation shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com